NASDAQ: ADXN
Addex Therapeutics Ltd Stock Forecast, Predictions & Price Target

Analyst price target for ADXN

Based on 1 analyst offering 12 month price targets for Addex Therapeutics Ltd

Min Forecast
$30.00+345.7%
Avg Forecast
$30.00+345.7%
Max Forecast
$30.00+345.7%

Should I buy or sell ADXN stock?

Based on 1 analyst offering ratings for Addex Therapeutics Ltd.

Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ADXN stock forecasts and price targets.

ADXN stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-10-02

1 of 1

Forecast return on equity

Is ADXN forecast to generate an efficient return?

Company
-4,429.9%
Industry
1,086.64%
Market
61.39%
ADXN's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ADXN forecast to generate an efficient return on assets?

Company
-4,027.24%
Industry
434.92%
ADXN is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ADXN earnings per share forecast

What is ADXN's earnings per share in the next 1 years based on estimates from 1 analyst?

Avg 1 year Forecast
-$5.60-9,591.53%

ADXN revenue forecast

What is ADXN's revenue in the next 1 years based on estimates from 1 analyst?

Avg 1 year Forecast
$940.0k+34.88%

ADXN vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ADXN$6.73$30.00+345.70%Buy
ONVO$0.35N/AN/A
LIPO$4.32N/AN/A
AEON$0.14$5.00+3,603.70%Buy
ABVC$0.42N/AN/A

Addex Therapeutics Stock Forecast FAQ

Is Addex Therapeutics Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: ADXN) stock is to Buy ADXN stock.

Out of 1 analyst, 0 (0%) are recommending ADXN as a Strong Buy, 1 (100%) are recommending ADXN as a Buy, 0 (0%) are recommending ADXN as a Hold, 0 (0%) are recommending ADXN as a Sell, and 0 (0%) are recommending ADXN as a Strong Sell.

If you're new to stock investing, here's how to buy Addex Therapeutics stock.

What is ADXN's earnings growth forecast for 2025-2025?

(NASDAQ: ADXN) Addex Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of N/A, and while it is not forecast to beat the US market's average forecast earnings growth rate of N/A.

Addex Therapeutics's earnings in 2025 is $6,072,679.

In 2025, ADXN is forecast to generate -$550,612,720 in earnings, with the lowest earnings forecast at -$550,612,720 and the highest earnings forecast at -$550,612,720.

What is ADXN's revenue growth forecast for 2025-2025?

(NASDAQ: ADXN) Addex Therapeutics's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of N/A, and while it is not forecast to beat the US market's average forecast revenue growth rate of N/A.

Addex Therapeutics's revenue in 2025 is $665,574.

In 2025, ADXN is forecast to generate $92,424,278 in revenue, with the lowest revenue forecast at $92,424,278 and the highest revenue forecast at $92,424,278.

What is ADXN's forecast return on assets (ROA) for 2025-2025?

(NASDAQ: ADXN) forecast ROA is -4,027.24%, which is lower than the forecast US Biotechnology industry average of 434.92%.

What is ADXN's Price Target?

According to 1 Wall Street analyst that have issued a 1 year ADXN price target, the average ADXN price target is $30.00, with the highest ADXN stock price forecast at $30.00 and the lowest ADXN stock price forecast at $30.00.

The Wall Street analyst predicted that Addex Therapeutics's share price could reach $30.00 by Oct 2, 2025. The average Addex Therapeutics stock price prediction forecasts a potential upside of 345.7% from the current ADXN share price of $6.73.

What is ADXN's Earnings Per Share (EPS) forecast for 2025-2025?

(NASDAQ: ADXN) Addex Therapeutics's current Earnings Per Share (EPS) is $0.06. In 2025, ADXN's EPS is forecast to hit -$5.60 (min: -$5.60, max: -$5.60).

What is ADXN's forecast return on equity (ROE) for 2025-2025?

(NASDAQ: ADXN) forecast ROE is -4,429.9%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.